Recurrent Implantation Failure: Causes, Testing, and What Comes Next
Few moments in fertility care are harder than a negative pregnancy test after an embryo transfer — especially when it isn't the first. When healthy-appearing embryos are transferred more than once without a resulting pregnancy, patients and physicians start asking a difficult question: why isn't this working, and what should we do differently?
That situation is often called recurrent implantation failure (RIF). It's a real and frustrating experience — but it's also one of the most misunderstood terms in fertility medicine. The good news, grounded in the most current guidance from the American Society for Reproductive Medicine (ASRM), is that many patients who are told they have RIF still go on to have a baby, and that a focused, evidence-based approach usually matters more than an exhaustive one.
First, an important distinction: RIF is not recurrent miscarriage
These two terms are frequently confused, but they describe different problems:
-
Recurrent implantation failure (RIF) means embryos are transferred but never establish a pregnancy — there's no positive pregnancy test.
-
Recurrent pregnancy loss (RPL) means a pregnancy does begin — there's a positive test — but is then lost, sometimes more than once.
The distinction matters because the likely causes, the testing, and the next steps are different for each. This article is about implantation failure specifically. If you've had one or more pregnancies that ended in loss, our separate guide to recurrent pregnancy loss will be more relevant.
What actually counts as "recurrent implantation failure"?
Here's something many patients are surprised to learn: there is no single, universally agreed-upon definition of RIF. Historically it was described as failure to conceive after three transfers of good-quality embryos, but reproductive medicine has moved toward a more individualized view.
In its 2026 guidance, ASRM frames RIF around probability rather than a fixed count — essentially, implantation hasn't occurred even after transferring the number of good-quality embryos that would be expected to produce a pregnancy the large majority of the time. In practical terms, that often means somewhere around three to six failed transfers of chromosomally normal (euploid) embryos, or a larger number of untested embryos, depending on age.
Why does this nuance matter to you? Because how RIF is defined directly affects whether you're labeled with it — and an overly rigid definition can lead to over-testing and unnecessary worry. Age, embryo quality, how many embryos were transferred, and whether they were genetically tested all shape whether repeated failure reflects a real underlying problem or simply the normal odds playing out over a small number of transfers.
Why implantation fails: the biggest factor first
Implantation is a genuinely complex event — a viable embryo has to reach a receptive uterus at exactly the right moment. Things can go wrong on either the embryo side or the uterine side, but they are not equally common.
Embryo chromosomal normality is the single most important factor. According to ASRM, age-related chromosomal abnormality (aneuploidy) is believed to be the principal cause of implantation failure, because chromosomally abnormal embryos have very little ability to implant and sustain a pregnancy. This is the same biology that drives age-related fertility decline generally: the share of embryos that are chromosomally normal falls as egg age rises — from roughly 70% in a woman's early 30s to around half by age 38 and far lower into the 40s. An embryo can look perfect under the microscope and still be chromosomally abnormal, which is why even good-quality transfers sometimes fail. (Our guides to embryo grading and PGT-A genetic testing go deeper on this.)
Uterine and structural factors are less common but genuinely correctable, which is why they're worth checking. These include:
-
Polyps and submucosal fibroids that distort the uterine cavity
-
Scar tissue, a uterine septum, or hydrosalpinx (fluid-filled fallopian tube)
-
Chronic endometritis — a low-grade inflammation of the uterine lining
-
Endometriosis or adenomyosis, which may affect the uterine environment
Other contributors can include technical aspects of the embryo transfer itself and lifestyle factors such as smoking, which is clearly linked to lower implantation rates.
How recurrent implantation failure is evaluated
A thoughtful RIF evaluation starts not with a long list of tests, but with a careful review of what has already happened. ASRM emphasizes that a detailed look at your history and your prior IVF cycles is the most important step — and that if no clear, correctable cause turns up, extensive testing is usually unnecessary.
A reasonable, evidence-supported workup may include:
-
A close review of prior cycles — stimulation response, egg and embryo numbers, embryo quality and (if done) genetic testing results, and transfer details.
-
A look inside the uterus — using saline infusion sonohysterography, an HSG, hysteroscopy, or 3D ultrasound to check for polyps, fibroids, scar tissue, or a septum. Hysteroscopy has the advantage of sometimes treating what it finds in the same procedure.
-
Removing polyps or submucosal fibroids that are found in the cavity.
-
Testing and treating chronic endometritis if inflammation is suspected.
-
Genetic testing — PGT-A can be discussed if prior embryos were untested, as a way to understand whether embryo chromosomal status is the issue; in some cases, testing the parents' chromosomes (karyotype) is also considered.
-
Evaluation for endometriosis or adenomyosis, with treatment considered before a future transfer in selected cases.
A note on PGT-A worth keeping in perspective: while it can help explain whether embryo genetics are contributing and can help select which embryo to transfer, current evidence does not show that PGT-A by itself increases the chance of a live birth in RIF patients. It's a tool for insight and selection, discussed through shared decision-making — not a guaranteed fix.
A careful word about "add-on" tests and treatments
Because RIF is so emotionally difficult, it has attracted a large number of extra tests and treatments — often marketed directly to patients and frequently expensive. It's worth knowing what the evidence actually says before paying for them.
As of its 2026 review, ASRM found insufficient evidence to routinely recommend a number of popular add-ons for recurrent implantation failure, including:
-
Endometrial receptivity testing (ERA) to time the transfer — well-designed trials have not shown it improves live birth rates
-
Endometrial "scratch" procedures — evidence suggests this is not effective
-
Immune-based therapies such as intravenous immunoglobulin (IVIG), intralipid/fat-emulsion infusions, and steroids
-
Sperm DNA fragmentation testing in the RIF context
-
Blood-clotting (thrombophilia) testing and blood thinners in patients without a diagnosed clotting disorder
None of this means these approaches are universally useless, or that research won't eventually clarify a role for some of them in specific patients. It means the current evidence doesn't support using them routinely — so they're worth approaching with informed caution. A good question to ask any provider is simple: "What will this test change about my treatment, and what does the evidence say it does for someone like me?" Evidence-based, individualized care is the standard we hold ourselves to at Indiana Fertility Institute.
The reality that gives most patients hope
Perhaps the most important finding in the current guidance is also the most reassuring. Some researchers argue that "true" recurrent implantation failure is uncommon — that with continued transfers of chromosomally normal embryos, the large majority of patients eventually conceive. In other words, repeated failure over a small number of transfers is often the normal statistics of IVF playing out, not evidence of an insurmountable barrier.
That's why, when a careful evaluation doesn't reveal a clear, fixable cause, it is often entirely reasonable to continue with additional transfers rather than pursue endless testing. Persistence, combined with addressing any genuinely correctable factors, is frequently what leads to success.
Frequently asked questions
What is recurrent implantation failure? It's when embryos are transferred during IVF more than once but don't result in a pregnancy — meaning no positive pregnancy test. There's no single agreed definition, but it's often discussed after roughly three or more failed transfers of good-quality embryos, taking age and embryo genetics into account.
Is recurrent implantation failure the same as recurrent miscarriage? No. Implantation failure means a pregnancy never starts. Recurrent pregnancy loss means a pregnancy begins and is then lost. They have different causes and different evaluations.
What's the most common cause? Age-related chromosomal abnormalities in the embryo are believed to be the leading cause. An embryo can look healthy and still be chromosomally abnormal, which prevents it from implanting or leads to very early loss.
Does PGT-A fix recurrent implantation failure? PGT-A can help identify chromosomally normal embryos and clarify whether embryo genetics are the issue, but current evidence does not show that it increases live birth rates in RIF patients on its own. It's best thought of as a tool for insight and embryo selection.
Are treatments like ERA, endometrial scratch, or immune therapy worth it? Leading guidelines currently find insufficient evidence to recommend these routinely for RIF. They may be discussed in specific situations, but it's reasonable to ask what the evidence shows before pursuing them.
Can I still get pregnant after recurrent implantation failure? Often, yes. Many patients labeled with RIF go on to conceive, particularly once any correctable factors are addressed and transfers continue. A negative cycle is not the end of the road.
The bottom line
Recurrent implantation failure is one of the most disheartening experiences in fertility care — but it's also one where a calm, evidence-based approach matters enormously. The biggest driver is usually embryo chromosomal normality, a focused evaluation can catch the genuinely correctable causes, and many heavily-marketed add-on treatments simply aren't supported by strong evidence. Most importantly, repeated failure is not the same as never succeeding.
If you've had more than one embryo transfer without a pregnancy, the right next step is a thorough review with a reproductive endocrinologist who will look carefully at your history and help you separate what's worth doing from what isn't. Request a consultation with the team at Indiana Fertility Institute to talk through your specific situation and a plan built around the evidence.